Consolidated Statements of Changes in Equity - USD ($)	Total		Cumulative Effect, Period of Adoption, Adjustment	Total Stockholders' Equity	Total Stockholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid in Capital	Cumulative Distributions to Stockholders	Accumulated Earnings	Accumulated Earnings Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2021						2,400,000
Balance at Dec. 31, 2021	$ 169,375,500			$ 169,276,000		$ 57,254,935	$ 249,434	$ 233,833,749	$ (143,449,310)	$ 21,387,192		$ 99,500
Beginning balance (in shares) at Dec. 31, 2021							24,947,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)							27,283,269
Issuance of common stock	83,487,253			83,487,253			$ 272,818	83,214,435
Cost of issuing common stock	(2,446,970)			(2,446,970)				(2,446,970)
Restricted stock compensation expense	(2,830)			(2,830)				(2,830)
Net income	9,863,660			9,863,660						9,863,660
Common dividends declared	(12,535,116)			(12,535,116)					(12,535,116)
Preferred dividends declared	$ (4,740,000)			(4,740,000)					(4,740,000)
Ending balance (in shares) at Dec. 31, 2022	2,400,000					2,400,000
Balance at Dec. 31, 2022	$ 243,001,497	[1]	$ (3,591,440)	242,901,997	$ (3,591,440)	$ 57,254,935	$ 522,252	314,598,384	(160,724,426)	31,250,852	$ (3,591,440)	99,500
Ending balance (in shares) at Dec. 31, 2022	52,231,152						52,231,152
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13
Issuance of common stock (in shares)							17,479
Issuance of common stock	$ 53,516			53,516			$ 235	53,281
Cost of issuing common stock	(56,940)			(56,940)				(56,940)
Restricted stock compensation expense	(7,426)			(7,426)				(7,426)
Net income	19,714,496			19,714,496						19,714,496
Common dividends declared	(13,581,323)			(13,581,323)					(13,581,323)
Preferred dividends declared	$ (4,740,000)			(4,740,000)					(4,740,000)
Ending balance (in shares) at Dec. 31, 2023	2,400,000					2,400,000
Balance at Dec. 31, 2023	$ 240,792,380	[1]		$ 240,692,880		$ 57,254,935	$ 522,487	$ 314,587,299	$ (179,045,749)	$ 47,373,908		$ 99,500
Ending balance (in shares) at Dec. 31, 2023	52,248,631						52,248,631

[1] Our consolidated balance sheets include assets and liabilities of consolidated variable interest entities ("VIEs") as the Company was the primary beneficiary of these VIEs. As of December 31, 2023 and December 31, 2022, assets of the consolidated VIEs totaled $1,384,136,334 and $1,005,507,371, respectively and the liabilities of consolidated VIEs totaled $1,150,207,290 and $831,575,144, respectively. See Note 4 for further discussion.